179 related articles for article (PubMed ID: 17634199)
1. Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome.
McNicholas WT
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1666-70. PubMed ID: 17634199
[TBL] [Abstract][Full Text] [Related]
2. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities.
McNicholas WT; Bonsigore MR;
Eur Respir J; 2007 Jan; 29(1):156-78. PubMed ID: 17197482
[TBL] [Abstract][Full Text] [Related]
3. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk.
Parati G; Lombardi C; Narkiewicz K
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1671-83. PubMed ID: 17652356
[TBL] [Abstract][Full Text] [Related]
4. Effect of CPAP therapy on cardiovascular events and mortality in patients with obstructive sleep apnea: a meta-analysis.
Guo J; Sun Y; Xue LJ; Huang ZY; Wang YS; Zhang L; Zhou GH; Yuan LX
Sleep Breath; 2016 Sep; 20(3):965-74. PubMed ID: 26873722
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of continuous positive airway pressure therapy in reducing cardiovascular events in obstructive sleep apnea: a systematic review.
Parsons C; Allen S; Parish J; Mookadam F; Mookadam M
Future Cardiol; 2017 Jul; 13(4):397-412. PubMed ID: 28631492
[TBL] [Abstract][Full Text] [Related]
6. [Complex sleep apnea syndrome].
Palman AD
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(4. Vyp. 2):60-66. PubMed ID: 28777366
[TBL] [Abstract][Full Text] [Related]
7. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial.
Barbé F; Durán-Cantolla J; Sánchez-de-la-Torre M; Martínez-Alonso M; Carmona C; Barceló A; Chiner E; Masa JF; Gonzalez M; Marín JM; Garcia-Rio F; Diaz de Atauri J; Terán J; Mayos M; de la Peña M; Monasterio C; del Campo F; Montserrat JM;
JAMA; 2012 May; 307(20):2161-8. PubMed ID: 22618923
[TBL] [Abstract][Full Text] [Related]
8. Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.
Toraldo DM; De Benedetto M; Scoditti E; De Nuccio F
Sleep Breath; 2016 May; 20(2):457-65. PubMed ID: 26169715
[TBL] [Abstract][Full Text] [Related]
9. [Continuous positive airway pressure in obstructive sleep apnea].
Meurice JC; Antone E; Gilbert M; Watrin A; Bironneau V
Presse Med; 2017 Apr; 46(4):423-431. PubMed ID: 28434626
[TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular consequences of obstructive sleep apnea syndrome].
Lorenzi Filho G; Genta PR; Pedrosa RP; Drager LF; Martinez D
J Bras Pneumol; 2010 Jun; 36 Suppl 2():38-42. PubMed ID: 20944980
[TBL] [Abstract][Full Text] [Related]
11. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea.
Patruno V; Aiolfi S; Costantino G; Murgia R; Selmi C; Malliani A; Montano N
Chest; 2007 May; 131(5):1393-9. PubMed ID: 17494789
[TBL] [Abstract][Full Text] [Related]
12. Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea.
Pataka A; Riha RL
Curr Cardiol Rep; 2013 Aug; 15(8):385. PubMed ID: 23873341
[TBL] [Abstract][Full Text] [Related]
13. Severity of OSAS, CPAP and cardiovascular events: A follow-up study.
Baratta F; Pastori D; Fabiani M; Fabiani V; Ceci F; Lillo R; Lolli V; Brunori M; Pannitteri G; Cravotto E; De Vito C; Angelico F; Del Ben M
Eur J Clin Invest; 2018 May; 48(5):e12908. PubMed ID: 29424037
[TBL] [Abstract][Full Text] [Related]
14. Impact of Continuous Positive Airway Pressure on Cardiovascular Risk Factors in High-Risk Patients.
Zhao YY; Redline S
Curr Atheroscler Rep; 2015 Nov; 17(11):62. PubMed ID: 26370408
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome.
Doherty LS; Kiely JL; Swan V; McNicholas WT
Chest; 2005 Jun; 127(6):2076-84. PubMed ID: 15947323
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment.
Alkhalil M; Schulman ES; Getsy J
Ann Allergy Asthma Immunol; 2008 Oct; 101(4):350-7. PubMed ID: 18939721
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome.
Harsch IA; Hahn EG; Konturek PC
Med Sci Monit; 2005 Mar; 11(3):RA70-5. PubMed ID: 15735578
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic approach to nonsleepy apnea.
Montserrat JM; Garcia-Rio F; Barbe F
Am J Respir Crit Care Med; 2007 Jul; 176(1):6-9. PubMed ID: 17431227
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea.
Abuzaid AS; Al Ashry HS; Elbadawi A; Ld H; Saad M; Elgendy IY; Elgendy A; Mahmoud AN; Mentias A; Barakat A; Lal C
Am J Cardiol; 2017 Aug; 120(4):693-699. PubMed ID: 28651851
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular morbidity associated with obstructive sleep apnea syndrome].
Destors M; Tamisier R; Baguet JP; Levy P; Pepin JL
Rev Mal Respir; 2014 Apr; 31(4):375-85. PubMed ID: 24750957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]